Lead Sponsor

Cancer Intelligence Care Systems, Inc.

Collaborators

Age

20 - 85 years

Sex

ALL

Healthy Volunteers

No

•1. Patients with primary malignant melanoma or angiosarcoma diagnosed histopathologically
•2. Patients with superficial skin lesions whose maximum diameter of the target lesion is 15 cm or less
•3. Patients with lesions that are lying 6 cm or less from the skin surface to the deepest part of the tumor
•4. Patients with lesions in the head, neck, chest, or extremities
•5. Patients who do not have apparent abnormal hematological and biochemical values in the latest screening test within 28 days of registration

•1. Patients with obvious disseminated lesions
•2. Patients who have undergone previous treatment of radiation therapy exceeding 75 Gy for the target lesion.
•3. Patients with active lesions / active multiple cancers in addition to the target lesion
•4. Patients with infections that require systemic treatment.
•5. Patients with active implantable medical devices
•6. Patients with a history of BNCT treatment

Related studies

NCT07432932 · Sarcoma, Sarcoma, Leiomyo-, Adult, and more

NCT06715579 · Cardiac Angiosarcoma

NCT04055220 · Bone Sarcoma, Osteosarcoma, and more

NCT06440005 · Cancer, Advanced Cancer, and more

NCT07371663 · Solid Cancers, NSCLC (Advanced Non-small Cell Lung Cancer), and more

Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma